NeurOp

NeurOp, Inc. is an Atlanta-based clinical-stage biopharmaceutical company developing novel drugs for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage, and treatment-resistant depression. Its technology targets the GluN2B subunit of neuronal NMDA receptors and their potential therapeutic benefits.